LU88375A1 - Energy product stimulating male potency - Google Patents
Energy product stimulating male potency Download PDFInfo
- Publication number
- LU88375A1 LU88375A1 LU88375A LU88375A LU88375A1 LU 88375 A1 LU88375 A1 LU 88375A1 LU 88375 A LU88375 A LU 88375A LU 88375 A LU88375 A LU 88375A LU 88375 A1 LU88375 A1 LU 88375A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- product
- substances
- synthesis
- composition
- components
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
Description
BREVET EUROPEEN D'INVENTION LIGNE "Energie - Virilité"EUROPEAN PATENT OF INVENTION "Energy - Manhood" LINE
Produit: "VIRDAN"Product: "VIRDAN"
Ingrédients et compositions: (par comprimé- capsule)Ingredients and compositions: (per tablet - capsule)
Acides Ursodésoxycholique (UDCA) mg. 22,0Ursodeoxycholic acids (UDCA) mg. 22.0
Extrait de Panax Ginseng mg. 75,0Panax Ginseng extract mg. 75.0
Extrait de Muira Puama mg. 10,8Muira Puama mg extract. 10.8
Yolimbine Chlorhydrate mg. 2,8Yolimbine Hydrochloride mg. 2.8
Extrait de Guarana mg. 12,0Guarana extract mg. 12.0
Extrait de Noix Vomique mg. 1,5Vomic Nut Extract mg. 1.5
Extrait de Damiana mg. 23,0Damiana mg extract. 23.0
Nicotinamide mg. 28,0Nicotinamide mg. 28.0
Acide Nicotinique mg. 22,0Nicotinic acid mg. 22.0
Acétate de L-Tocophérol mg. 12,0L-Tocopherol acetate mg. 12.0
Clenbuterole Chlorhydrate mg. 0,012Clenbuterole Hydrochloride mg. 0.012
Adjuvants de fabrication = lactose, silice, talc, amidon, stéarate de magnésium.Manufacturing aids = lactose, silica, talc, starch, magnesium stearate.
Boite de 50 comprimés/capsules de 250 mg.Box of 50 tablets / capsules of 250 mg.
Poids net .......... ΘNet weight .......... Θ
Brevet Européen N°...........................du Professeur Michel URSO.European Patent N ° ........................... of Professor Michel URSO.
Produit par Laboratoires "MEDICAE". Mémoire descriptive du produit Ligne "Energie - Virilité - Produit: "VIRDAN"Produced by Laboratoires "MEDICAE". Descriptive memory of the product Line "Energy - Virility - Product:" VIRDAN "
Premier chapitreFirst chapter
Description de l'invention: 1) Le titre de cette invention est "VIRDAN" 2) Le domaine technique auquel elle se rapporte est celui du domaine scientifique des vaso-dilatateurs, des sympatholytiques et des stimulants. 3) La technique antérieure comprenait l'emploi de produits différents,composition et principes actifs.Description of the invention: 1) The title of this invention is "VIRDAN" 2) The technical field to which it relates is that of the scientific field of vasodilators, sympatholytics and stimulants. 3) The prior art included the use of different products, composition and active ingredients.
Nous avons étudié et découvert, en milieu clinique l'utilité de lier diverses substances entre elles en doses suffisantes pour faciliter l'action vaso-dilatatrice périphérique et en même temps stimuler l'action sympatholytique et stimulatrice du S.N.C.We have studied and discovered, in clinical settings, the usefulness of binding various substances together in sufficient doses to facilitate the peripheral vasodilator action and at the same time stimulate the sympatholytic and stimulating action of S.N.C.
Le "VIRDAN" qui a été découvert, est une molécule complexe qui dérive de l'union de particulières molécules, de façons à donner au produit une caractéristique typique, pour son usage.The "VIRDAN" which has been discovered, is a complex molecule which derives from the union of particular molecules, in ways to give the product a typical characteristic, for its use.
Avant d'expliquer les propriétés de chaque composant, il faut parler en synthèses des problèmes et connaissances médicales sur l'argument traité en raison du produit étudié. La science médicale, à présent classifie les cause d'impuissance en: I) Organiques (due au système vasculaire et système nerveux central et périphérique). \\) PsvchoaènesBefore explaining the properties of each component, it is necessary to speak in summary of the medical problems and knowledge on the argument treated because of the product studied. Medical science now classifies the causes of impotence into: I) Organic (due to the vascular system and central and peripheral nervous system). \\) Psvchoaènes
Le système nerveux central donne stimulation érotique sensitive et stimulation psychique.The central nervous system provides sensitive erotic stimulation and psychic stimulation.
Le système nerveux périphérique est composé de: - nerfs ortho-sympathiques, d'origine lombaire (D10-L2) responsable de Vasoconstriction sur "Shunts artèriel-veineux". - nerfs para-sympathiques avec origine sacré (S2-S4) avec action vaso-dilatatrice.The peripheral nervous system is composed of: - ortho-sympathetic nerves, of lumbar origin (D10-L2) responsible for Vasoconstriction on "Arterial-venous shunts". - para-sympathetic nerves with sacred origin (S2-S4) with vasodilating action.
Le résultat de l'ensemble est l'activation emo-dynamique avec action sur Içs centres midollaires , (lombaire et sacré), pour obtenir l'hyper-afflux artériel et réduction de l'effluve veineux par bloc mécanique.The result of the whole is the emo-dynamic activation with action on these midollar centers, (lumbar and sacral), to obtain arterial hyper-influx and reduction of venous effluvium by mechanical block.
Donc pour obtenir de bons résultats dans ce domaine, il faut agir avec diverses substances sur le système nerveux central avec des excitants, sur le centre midollaire avec sympathomimétiques et stimulants, et sur le système vasculaire avec vaso-actifs périphériques.So to obtain good results in this area, it is necessary to act with various substances on the central nervous system with stimulants, on the midollar center with sympathomimetics and stimulants, and on the vascular system with peripheral vaso-active agents.
Nous avons fait des recherches scientifiques et des études pour ce problème, et nous avons eu de bons résultats et de bonnes réponses sur des patients, après usage du produit pour une période d'un mois.We have done scientific research and studies for this problem, and we have had good results and good responses in patients, after using the product for a period of one month.
En ce qui concerne les composants du produit, nous donnons une explication pour chacun. - L'acide Ursodesoxycholique: exerce une action protectrice sur le foie et les voies biliaires. - Le Panax Ginseng: de Corée est une racine célèbre ches les chinois pour ses vertus. Le vrai Ginseng chinois contient de l'amidon, et divers acides et un phytostérol.Regarding the components of the product, we give an explanation for each. - Ursodesoxycholic acid: exerts a protective action on the liver and bile ducts. - Panax Ginseng: from Korea is a root famous in China for its virtues. Real Chinese Ginseng contains starch, and various acids and phytosterol.
Il exerce une action sur le Cortex par excitation et inhibition visant le système nerveux central, mais toujours dans le sens favorable, avec un accélérateur des phénomènes sexuels. - Le Guarana: matière médicamenteuse préaprée avec les semences de Paullinia Cupana, qui contient environ de 4% à 6% de Guaranine ( Cs H10 N4 O2) identique à la caféine. Exerce une action cardio-tonique et aphrodisiaque. Ne cause pas d'insomnie ni d'agitation nerveuse. - Le Yohimbine: est un alcaloïde avec des propriétés chimiques et physiologique propre de (C21 H26 O3 N2) (sympatholytiques). qui exerce aussi une action aphrodisiaques. Aussi employé contre l'impuissance due à un problème neurasthénique. - Le Muira Puama: est une plante du Brésil, reconnue pour sa propriété aphrodisiaque et tonifiante. Elle exerce son action sur le système nerveux central. - La Noix Vomiaue: reforce deux Alcaloïdes, le Strychnine et la Lorucine. Les effets physiologique sont ceux de la Strychnine. A dose minimum elle exalte favorablement l'excitabilité réflexe. L'emploi thérapeutique est celui de stimuler quand on a insuffisance de l'activité bulbe-midoilaire et asthénie sexuelle (impuissance). - Le Damiana: dit "turnera aphrodisiaque" est une plante poussant au Mexique et en Californie. Elle contient du tanin (3,5 %), des résines (14 %). Elle possède des propriétés tonique et aphrodisiaque, en agissant sur le centre sacré (nerf parasympathique). - Le Nicotinamide: est un co-enzyme intervenant dans le processus d'oxydo-réduction dans l'organisme. Il a aussi une action vaso-dilatatrice.It exerts an action on the Cortex by excitation and inhibition targeting the central nervous system, but always in the favorable direction, with an accelerator of sexual phenomena. - Guarana: medicinal material pre-prepared with the seeds of Paullinia Cupana, which contains approximately 4% to 6% of Guaranine (Cs H10 N4 O2) identical to caffeine. Has a cardio-tonic and aphrodisiac action. Does not cause insomnia or nervous agitation. - Yohimbine: is an alkaloid with its own chemical and physiological properties of (C21 H26 O3 N2) (sympatholytics). which also exerts an aphrodisiac action. Also used against impotence due to a neurasthenic problem. - Muira Puama: is a plant from Brazil, recognized for its aphrodisiac and invigorating property. It exerts its action on the central nervous system. - La Vixia Vomiaue: strengthens two alkaloids, Strychnine and Lorucine. The physiological effects are those of Strychnine. At a minimum dose it positively enhances reflex excitability. The therapeutic use is that of stimulating when one has insufficiency of the bulb-midoilaire activity and sexual asthenia (impotence). - Damiana: called "turnera aphrodisiac" is a plant growing in Mexico and California. It contains tannin (3.5%), resins (14%). It has tonic and aphrodisiac properties, acting on the sacred center (parasympathetic nerve). - Nicotinamide: is a co-enzyme involved in the redox process in the body. It also has a vasodilating action.
Claims (2)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
LU88375A LU88375A1 (en) | 1993-07-12 | 1993-07-12 | Energy product stimulating male potency |
FR9408550A FR2710267B3 (en) | 1993-07-12 | 1994-07-11 | Composition for the treatment of male impotence. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
LU88375A LU88375A1 (en) | 1993-07-12 | 1993-07-12 | Energy product stimulating male potency |
Publications (1)
Publication Number | Publication Date |
---|---|
LU88375A1 true LU88375A1 (en) | 1994-04-01 |
Family
ID=19731421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU88375A LU88375A1 (en) | 1993-07-12 | 1993-07-12 | Energy product stimulating male potency |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR2710267B3 (en) |
LU (1) | LU88375A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1407778A1 (en) * | 1997-12-08 | 2004-04-14 | PhytoFit Ltd | Compositions and methods for weight reduction |
EA002965B1 (en) * | 1997-12-08 | 2002-12-26 | Натурал Медико Тех А/С | Compositions for weight reduction |
US7772220B2 (en) | 2004-10-15 | 2010-08-10 | Seo Hong Yoo | Methods and compositions for reducing toxicity of a pharmaceutical compound |
NL1011082C2 (en) * | 1999-01-20 | 2000-07-21 | Danny Van Eijsselsteijn | Herbal composition for increasing erogenous sensitivity, especially in women, comprises muira puama and damiana |
WO2001068137A2 (en) * | 2000-03-14 | 2001-09-20 | Brown University Research Foundation | Compositions for regulating memory consolidation |
MXPA05003285A (en) * | 2002-09-28 | 2005-07-05 | Boehringer Ingelheim Int | Composition comprising panax ginseng and paullinia cupana extracts. |
EP1457209A1 (en) * | 2003-03-12 | 2004-09-15 | Pharmaton S.A. | Composition for the enhancement of cognitive skills comprising Panax ginseng and Paullinia cupana extracts |
US7145125B2 (en) | 2003-06-23 | 2006-12-05 | Advanced Optical Technologies, Llc | Integrating chamber cone light using LED sources |
ES2339790T3 (en) | 2004-08-30 | 2010-05-25 | Seo Hong Yoo | NEUOPROTECTOR EFFECT OF UDCA SOLUBILIZED IN FOCAL ISCHEMICAL MODEL. |
CA2584184A1 (en) | 2004-10-15 | 2006-04-27 | Seo Hong Yoo | Methods and compositions for reducing toxicity of a pharmaceutical compound |
CN101065110A (en) * | 2004-11-24 | 2007-10-31 | 柳署弘 | Dried forms of aqueous solubilized bile acid dosage formulation, preparation and uses thereof |
CN114642629A (en) * | 2022-03-22 | 2022-06-21 | 四川中天鑫源生命科技有限公司 | Compound gel preparation and preparation method, administration mode and application thereof |
-
1993
- 1993-07-12 LU LU88375A patent/LU88375A1/en unknown
-
1994
- 1994-07-11 FR FR9408550A patent/FR2710267B3/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
FR2710267B3 (en) | 1995-10-13 |
FR2710267A1 (en) | 1995-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LU88375A1 (en) | Energy product stimulating male potency | |
CN106214989A (en) | A kind of defying age, the deer's blood health-care medicated wine improving memory and preparation method thereof | |
WO2005120536A1 (en) | Ginseng composition for preventing or improving the lowering of concentration and memory capability | |
CN105920476A (en) | Traditional Chinese medicine composition for prophylaxis and treatment of Alzheimer disease and preparation method thereof | |
CN110742972B (en) | Traditional Chinese medicine composition with cognitive improvement effect and preparation method thereof and traditional Chinese medicine preparation | |
CN105232907A (en) | Beverage capable of invigorating kidney and strengthening Yang and making method thereof | |
CN101804127B (en) | Compound traditional Chinese medicine extractive composite for preventing and curing Alzheimer disease | |
CN100522193C (en) | Use of Broussonetia papyrifera red pigment | |
CN104225417A (en) | Traditional Chinese medicine composition with function of assisting improvement of memory and preparation method thereof | |
KR100518179B1 (en) | Composition for improvement of sexual function | |
CN102204676B (en) | Food for resisting sleep deprivation stress damage | |
CN106690201A (en) | Composition with immunity enhancing function and preparation method thereof | |
CN104547830B (en) | A kind of brain boosting oral liquid and preparation method thereof | |
BRPI0106382B1 (en) | PROCESS FOR OBTAINING DECOCTS FROM VITIS LABRUSCA AND VITIS VINIFERA CASTS, PROCESS FOR OBTAINING THE HYDRO-ALCOHOLIC EXTRACT, PROCESS FOR OBTAINING THE HYDRO-ALCOHOLIC EXTRACT | |
CN104256618B (en) | A kind of hypoglycemic food, health products or pharmaceutical composition | |
KR101982129B1 (en) | Beverage for relieving hangover and manufacfuring method thereof | |
CN105998997A (en) | Oral liquid and preparation method thereof | |
EP0313945A2 (en) | Medicament for the treatment of hypertension and cardiac insufficiency | |
CN108853464A (en) | A kind of preparation method of ginkgo-leaf oral liquor | |
Ugwu et al. | Health implications of kolanut production and consumption | |
CN105998996A (en) | Medicinal liquor and preparation method thereof | |
RU2245717C1 (en) | Method for treating skin diseases | |
RU2102995C1 (en) | Medicinal preparation for persons born under the "cancer" sigh of the zodiac | |
CN107582621B (en) | Medicine for relaxing vascular smooth muscle and preparation method thereof | |
CN101176770B (en) | Pharmaceutical composition of folium ginkgo and cattail pollen |